Erdheim-Chester Disease Involving the Biliary System and Mimicking Immunoglobulin G4-Related Disease: A Case Report
Overview
Overview
Authors
Affiliations
Affiliations
Soon will be listed here.
Abstract
First described in 1930 as a lipoid granulomatosis, Erdheim-Chester disease (ECD) is a rare histiocytosis encompassing a group of disorders caused by overproduction of histiocytes, a subtype of white blood cells. This disease most commonly involves the bones and can affect organs in the abdomen; however, biliary involvement is rarely reported. We report a case of ECD with biliary involvement, which rendered it difficult to radiologically distinguish ECD from immunoglobulin G4-related disease.
References
1.
Kumar P, Singh A, Gamanagatti S, Kumar S, Chandrashekhara S
. Imaging findings in Erdheim-Chester disease: what every radiologist needs to know. Pol J Radiol. 2018; 83:e54-e62.
PMC: 6047091.
DOI: 10.5114/pjr.2018.73290.
View
2.
Young J, Johnson G, Murphy R, Go R, Broski S
. F-FDG PET/CT in Erdheim-Chester Disease: Imaging Findings and Potential BRAF Mutation Biomarker. J Nucl Med. 2017; 59(5):774-779.
DOI: 10.2967/jnumed.117.200741.
View
3.
Lee H, Lee K, Shin D, Lee Y, Choi S, Moon K
. A case of erdheim-chester disease with asymptomatic renal involvement. Cancer Res Treat. 2012; 44(2):146-50.
PMC: 3394865.
DOI: 10.4143/crt.2012.44.2.146.
View
4.
Zaveri J, La Q, Yarmish G, Neuman J
. More than just Langerhans cell histiocytosis: a radiologic review of histiocytic disorders. Radiographics. 2014; 34(7):2008-24.
DOI: 10.1148/rg.347130132.
View
5.
Goyal G, Heaney M, Collin M, Cohen-Aubart F, Vaglio A, Durham B
. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood. 2020; 135(22):1929-1945.
DOI: 10.1182/blood.2019003507.
View